We are a spin-off company from Pere Virgili Health Research institute (IISPV) and Rovira Virgili University. We are expert in succinate and are developing first-in-class molecules able to modulate succinate, a metabolite with pro-inflammatory properties that is increased in many metabolic and inflammatory disorders. The company has a diversified pipeline of candidates at an early preclinical phase and is working with several clinical indicacions, which include Type 2 Diabetes, obesity, Inflammatory bowel Disease and Non-Alcoholic Steatohepatitis
Company Details
- Employees
- 5
- Founded
- 2022
- Address
- Mallafre Guasch 4, Tarragona,spain
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.succipro.com
- Keywords
- Barcelona.
- HQ
- Tarragona
Succipro Questions
Succipro's website is http://www.succipro.com
Succipro's LinkedIn profile is https://es.linkedin.com/company/succipro
Succipro has
5 employees.
View email and phone details for 5
employees at Succipro.
Succipro's industry is
Biotechnology Research
Succipro's top competitors are
Nuage Therapeutics,
Trioteca,
Theker Robotics,
Incapto,
Affirma Biotech Sl,
Nocturna Therapeutics,
Pulmobiotics Sl,
Gate2brain,
Catalonia.health,
Oniria Therapeutics.
Succipro's categories are Biotechnology Research
Succipro's founding year is 2022
